Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.53 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.53 |
| ▸ | PRKCA | P17252 | 3/20 | 0.49 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.49 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.49 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5199055 | 1.00 | MAPT (0.56) | MAPTMAPK1GPR84FFAR1PRKCA | |
| SCHEMBL8772487 | 1.00 | MAPT (0.56) | MAPTMAPK1GPR84FFAR1PRKCA | |
| SCHEMBL10712293 | 1.00 | MAPT (0.56) | MAPTMAPK1GPR84FFAR1PRKCA | |
| Ethylene Glycol SCHEMBL27039268 | 0.97 | MAPT (0.53) | MAPTMAPK1GPR84FFAR1PRKCA | |
| Propene SCHEMBL4995113 | 0.92 | MAPT (0.49) | MAPTMAPK1GPR84FFAR1PRKCA | |
| SCHEMBL10715157 | 0.91 | FAAH (0.56) | MAPTPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL3312860 | 0.89 | GPR84 (0.57) | MAPTMAPK1GPR84FFAR1LMNA | |
| SCHEMBL29697233 | 0.89 | GPR84 (0.57) | MAPTMAPK1GPR84FFAR1LMNA | |
| SCHEMBL30778412 | 0.89 | GPR84 (0.57) | MAPTMAPK1GPR84FFAR1LMNA | |
| SCHEMBL223182 | 0.89 | GPR84 (0.57) | MAPTMAPK1GPR84FFAR1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 934 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4554379-B1 | USE OF AN ALKANEDIOL AS HERBICIDE | APEO AGRONOMICAL PLANT EXTRACTS & ESSENTIAL OILS (BE) | 2026-05-27 | — | — | EP | claimed |
| US-12527750-B2 | Pharmaceutical compositions comprising isotretinoin and processes for preparation and uses thereof | Acrotech Biopharma Inc. (US) | 2026-01-20 | — | — | US | claimed |
| EP-4658106-A1 | STABILIZED AEROSOL PRECURSOR FORMULATIONS | RAI Strategic Holdings, Inc. (US) | 2025-12-10 | — | — | EP | claimed |
| EP-4554379-A1 | USE OF AN ALKANEDIOL AS HERBICIDE | Apeo - Agronomical Plant Extracts & Essential Oils (BE) | 2025-05-21 | — | — | EP | claimed |
| CN-119950329-A | Composition for preparing high-caking-point emulsified product and application thereof | 上海妆修科技有限公司 | 2025-05-09 | — | — | CN | claimed |
| CN-119799167-A | Chemical mechanical polishing liquid for silicon wafer, preparation method and application | 万华化学集团股份有限公司 | 2025-04-11 | — | — | CN | claimed |
| EP-4531810-A1 | AQUEOUS PHARMACEUTICAL COMPOSITIONS COMPRISING SGLT-2 INHIBITORS | Boehringer Ingelheim Vetmedica GmbH (DE) | 2025-04-09 | — | — | EP | claimed |
| CN-119587389-A | Soap-based cleansing composition with high fatty acid content, and preparation method and application thereof | 广州极男化妆品有限公司 | 2025-03-11 | — | — | CN | claimed |
| CN-119177142-A | Novel amino acid contourable cream soap and preparation method thereof | 广州市朗怡日用化工有限公司 | 2024-12-24 | — | — | CN | claimed |
| CN-119110722-A | Aqueous pharmaceutical composition comprising an SGLT-2 inhibitor | 勃林格殷格翰动物保健有限公司 | 2024-12-10 | — | — | CN | claimed |
| EP-1945706-A1 | INTERCALATED LAYERED SILICATE | Cryovac, Inc. (US) | 2008-07-23 | — | — | EP | claimed |
| US-7273624-B2 | Stable dosage forms containing ubiquinones | ABBOTT GMBH & CO. KG (DE) | 2007-09-25 | — | — | US | claimed |
| WO-2007024564-A1 | INTERCALATED LAYERED SILICATE | CRYOVAC, INC. (US) | 2007-03-01 | — | — | WO | claimed |
| US-20040014817-A1 | Stable dosage forms containing ubiquinones | ABBOTT GMBH & CO. KG (DE) | 2004-01-22 | — | — | US | claimed |
| US-6599528-B1 | Mechanically stable pharmaceutical presentations form containing liquid or semisolid surface-active substances | ABBOTT GMBH & CO. KG (DE) | 2003-07-29 | — | — | US | claimed |
| EP-1014916-B1 | FOAMING SKIN CREAM, USES THEREOF AND A METHOD FOR PRODUCING THE SAME | NEUBOURG STEPHANIE (DE) | 2001-12-19 | — | — | EP | claimed |
| CN-1048740-C | Stretched film containing filler | MITSUBISHI CHEMICALS K K (JP) | 2000-01-26 | — | — | CN | claimed |
| CN-1056113-A | The stretched film that contains filler | MITSUBISHI PETROCHEMICAL CO (JP) | 1991-11-13 | — | — | CN | claimed |
| US-5006170-A | Thermal ink jet printing, binders, propellants | XEROX CORPORATION (US) | 1991-04-09 | — | — | US | claimed |
| EP-0013755-B1 | BEESWAX SUBSTITUTE BASED ON GLYCERIDES OF HIGHER FATTY ACIDS AND ITS USE | Henkel Kommanditgesellschaft auf Aktien (DE) | 1983-06-22 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12527750-B2 | Pharmaceutical compositions comprising isotretinoin and processes for preparation and uses thereof | STRA6, LRAT, DGAT2 | MAPT 728/4885MAPK1 3314/4885GPR84 371/4885 |
| US-20040014817-A1 | Stable dosage forms containing ubiquinones | NDUFB5, NDUFB7, NDUFA6 | MAPT 1980/4885MAPK1 4309/4885GPR84 4482/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.